Total parathyroidectomy with forearm auto-transplantation improves the quality of life and reduces the recurrence of secondary hyperparathyroidism in chronic kidney disease patients

Jiagen Li, Zhousheng Xiao, Xian-Jie Hu, Yun Li, Xing Zhang, Songze Zhang, Shan AiqinMedicine 2017 · DOI

TL;DR

This study investigates the effectiveness of total parathyroidectomy with forearm autotransplantation (PTX+FAT) compared to total parathyroidectomy alone (PTX) for treating secondary hyperparathyroidism (SHPT) in chronic kidney disease patients. The findings suggest that PTX+FAT significantly improves patients' quality of life and reduces the recurrence rate of SHPT.

What Problem Does This Paper Address?

Secondary hyperparathyroidism (SHPT) is a serious complication for patients with end-stage renal disease (ESRD), often persisting even after kidney transplantation. SHPT is characterized by overactive parathyroid glands, leading to bone disease, calcifications, and increased cardiovascular risk. While surgical intervention like parathyroidectomy (PTX) is used, recurrence remains a challenge. This paper explores whether adding forearm autotransplantation (FAT) to total PTX can offer a better solution by improving patient outcomes and reducing recurrence rates.

Methods

The study involved 104 chronic kidney disease patients with SHPT, divided into two groups: those who underwent total parathyroidectomy (PTX, n=62) and those who had total parathyroidectomy with forearm autotransplantation (PTX+FAT, n=42).

Key aspects of their methodology include:

  • Diagnosis Criteria: SHPT was diagnosed based on specific criteria including elevated intact parathyroid hormone (iPTH) levels (>600 pg/mL), calcium and phosphorus imbalances, unresponsiveness to medical therapy, severe osteoporosis, and significant clinical symptoms.
  • Surgical Procedures:
    • PTX: Standard total parathyroidectomy involving the removal of all parathyroid tissue.
  • PTX+FAT: Total parathyroidectomy with the implantation of small parathyroid tissue fragments into the forearm muscles. This aims to preserve some parathyroid function while removing the bulk of the diseased tissue.
  • Efficacy Evaluation: The study assessed the effectiveness of the procedures by monitoring:
  • Biochemical Markers: Levels of iPTH, serum calcium, serum phosphorus, and alkaline phosphatase (ALP) were measured at various time points post-operation.
  • Clinical Symptoms: Bone pain, skin pruritus, fractures, deformities, short stature, and coronary artery calcification (CAC) were tracked.
  • Quality of Life: The MOS 36-item short-form health survey (SF-36) was used to measure patients' quality of life.
  • Follow-up: Patients were followed for 12 months post-operation, with monthly check-ins.
  • Statistical Analysis: Standard statistical methods like t-tests, ANOVA, and Chi-square tests were used for comparisons. Binary logistic regression was employed to identify risk factors for recurrence.

Datasets

Not discussed in the paper. The study utilized data collected from patients undergoing surgery at Yinzhou Hospital of Ningbo University Medical College.

Key Insights and Ideas

  • FAT as a Protective Factor: The addition of forearm autotransplantation (FAT) to total parathyroidectomy (PTX) appears to be more than just a way to preserve some function; it significantly impacts long-term outcomes.
  • Improved Quality of Life: Both PTX and PTX+FAT improved patients' quality of life as measured by the SF-36, but the PTX+FAT group showed a more sustained and significant improvement, particularly at later time points.
  • Reduced Recurrence: The most striking finding is the significantly lower recurrence rate of SHPT in the PTX+FAT group compared to the PTX-only group. This suggests FAT plays a crucial role in preventing the return of hyperparathyroidism.
  • Biochemical Balance: While both procedures normalized iPTH and phosphorus, the PTX+FAT group showed a more favorable balance with increased serum calcium and a more consistent reduction in calcium-phosphorus product over time.
  • Risk Factor Identification: Preoperative iPTH levels, SF-36 scores, and the type of surgical procedure (PTX vs. PTX+FAT) were identified as significant risk factors for SHPT recurrence.

Key Results

  • Biochemical Markers: Both PTX and PTX+FAT groups showed decreased iPTH and serum phosphorus post-operation. However, the PTX+FAT group exhibited significantly higher serum calcium and calcium-phosphorus product levels at 3, 6, and 12 months post-operation compared to the PTX group.
  • Symptoms and Signs: Bone pain and skin pruritus decreased in both groups. Fractures, deformities, and short stature showed significant improvement in the PTX+FAT group at 6 and 12 months compared to the PTX group. Coronary artery calcification (CAC) also decreased more significantly in the PTX+FAT group at 6 months.
  • Quality of Life (SF-36): SF-36 scores increased significantly in both groups post-operation. The PTX+FAT group showed a statistically significant increase in SF-36 scores at 6 and 12 months compared to the PTX group.
  • Complications and Recurrence: While complication rates were similar between the groups, the recurrence rate was significantly lower in the PTX+FAT group (P<.05). The PTX group had a higher incidence of recurrent laryngeal nerve injury and severe low calcium convulsions.
  • Risk Factors for Recurrence: Logistic regression analysis identified high preoperative iPTH, low preoperative SF-36 score, and undergoing PTX alone (as opposed to PTX+FAT) as significant risk factors for SHPT recurrence.

Limitations and Future Work

  • Sample Size: The authors acknowledge that the sample size was relatively small, which may limit the generalizability of the findings and the ability to definitively determine the most appropriate approach for SHPT.
  • Follow-up Duration: The follow-up period of 12 months is considered short. Longer follow-up durations are needed to fully assess the long-term efficacy and durability of the PTX+FAT procedure.
  • Future Directions: The authors suggest that further studies with larger sample sizes and extended follow-up periods are necessary to solidify these findings and provide more robust evidence for the optimal surgical management of SHPT.

Summary updated

Abstract

Total PTX combined with FAT is more effective in improving the quality of life and reducing the recurrence of chronic kidney disease with SHPT than PTX alone.
BibTeX
@inproceedings{li2017total,
  author = {Jiagen Li and Zhousheng Xiao and Xian-Jie Hu and Yun Li and Xing Zhang and Songze Zhang and Shan Aiqin},
  title = {{Total parathyroidectomy with forearm auto-transplantation improves the quality of life and reduces the recurrence of secondary hyperparathyroidism in chronic kidney disease patients}},
  booktitle = {Medicine},
  year = {2017},
  doi = {10.1097/md.0000000000009050},
}
Figure